首页> 外文期刊>Antimicrobial agents and chemotherapy. >Fluoroquinolone resistance in atypical pneumococci and oral streptococci: evidence of horizontal gene transfer of fluoroquinolone resistance determinants from Streptococcus pneumoniae.
【24h】

Fluoroquinolone resistance in atypical pneumococci and oral streptococci: evidence of horizontal gene transfer of fluoroquinolone resistance determinants from Streptococcus pneumoniae.

机译:非典型肺炎球菌和口服链球菌中的氟喹诺酮耐药性:肺炎链球菌氟喹诺酮耐药性决定因素水平基因转移的证据。

获取原文
获取原文并翻译 | 示例
           

摘要

Atypical strains, presumed to be pneumococcus, with ciprofloxacin MICs of > or =4.0 microg/ml and unique sequence variations within the quinolone resistance-determining regions (QRDRs) of the gyrase and topoisomerase genes in comparison with the Streptococcus pneumoniae R6 strain, were examined. These strains were reidentified using phenotypic methods, including detection of optochin susceptibility, bile solubility, and agglutination by serotype-specific antisera, and genotypic methods, including detection of pneumolysin and autolysin genes by PCR, 16S rRNA sequencing, and multilocus sequence typing (MLST). The analysis based on concatenated sequences of the six MLST loci distinguished the "atypical" strains from pneumococci, and these strains clustered closely with S. mitis. However, all these strains and five of nine strains from the viridans streptococcal group possessed one to three gyrA, gyrB, parC, and parE genes whose QRDR sequences clustered with those of S. pneumoniae, providing evidence of horizontal transfer of the QRDRs of the gyrase and topoisomerase genes from pneumococci into viridans streptococci. These genes also conferred fluoroquinolone resistance to viridans streptococci. In addition, the fluoroquinolone resistance determinants of 32 well-characterized Streptococcus mitis and Streptococcus oralis strains from bacteremic patients were also compared. These strains have unique amino acid substitutions in GyrA and ParC that were distinguishable from those in fluoroquinolone-resistant pneumococci and the "atypical" isolates. Both recombinational events and de novo mutations play an important role in the development of fluoroquinolone resistance.
机译:与肺炎链球菌R6菌株相比,检查了假定为肺炎球菌的非典型菌株,环丙沙星MIC≥4.0或= 4.0 microg / ml,在回旋酶和拓扑异构酶基因的喹诺酮耐药性决定区(QRDR)内具有独特的序列变异。 。使用表型方法对这些菌株进行了重新鉴定,包括通过血清型特异性抗血清检测卵白蛋白敏感性,胆汁溶解性和凝集,以及通过PCR,16S rRNA测序和多基因座序列分型(MLST)检测基因型方法,包括检测肺炎球菌溶血素和自溶素基因。 。基于六个MLST基因座的串联序列进行的分析将“非典型”菌株与肺炎链球菌区分开,并且这些菌株与链球菌紧密结合。然而,所有这些菌株和viridans链球菌组的9株菌株中的5株具有1-3个gyrA,gyrB,parC和parE基因,它们的QRDR序列与肺炎链球菌的QRDR序列成簇,这提供了回旋酶QRDRs水平转移的证据。和拓扑异构酶基因从肺炎链球菌转变为绿色链球菌。这些基因还赋予氟喹诺酮对绿藻链球菌的抗性。此外,还比较了来自细菌性患者的32例特征明确的链球菌和口头链球菌的氟喹诺酮耐药性决定因素。这些菌株在GyrA和ParC中具有独特的氨基酸取代,可与耐氟喹诺酮的肺炎球菌和“非典型”分离株中的氨基酸取代区分开。重组事件和从头突变都在氟喹诺酮耐药性的发生中发挥重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号